Thursday 22th of April, CoEHAR organizes the kick-off online meeting of the Smile Study

The Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) is pleased to present the "Smile Study", a new research project committed to reducing the damage caused by smoking to dental health. On Thursday 22th of April, from 9.30 to 16.00, the CoEHAR organizes the kick-off online meeting of the Smile Study international research […]

Moldavia: Conference presenting the DIASMOKE international project

Meeting agenda: Opening remarks and greetings. University introduction and main collaboration prospective Prof. Emil CEBAN, rector of Nicolae Testemitanu University Strategic priorities for research development within Nicolae Testemitanu University. Academician […]

Seminar: Living systematic review with Renèe O’Leary

Tuesday 16 November at 14.00 CET a seminar on "Living systematic review: a new standard for medical research questions" will be held online on the ZOOM Platform direct by dr. Renèe O'Leary, project leader by In Silico Science. Opening panelist: prof. Riccardo Polosa, CoEHAR Founder and prof. Giovanni Li Volti, CoEHAR Director. CoEHAR researchers will take part […]

The E-Cigarette Summit 2021

The UK E-Cigarette Summit which will take place virtually on 7-8 December 2021 and hope that the Virtual Summit will provide a welcoming focal point to grapple with the challenging […]

FDA Grand Rounds

Development and Testing of Warnings for Tobacco Products: Scientific and Regulatory Considerations

TPE

TPE 2022 will be held at the Las Vegas Convention Center January 26-28, 2022 for 3 days of in-person business and networking.

Understanding Synthetic Nicotine: A Comprehensive Scientific and Legal Review

Webinar Understanding Synthetic Nicotine: A Comprehensive Scientific and Legal Review The webinar will begin with a scientific review of synthetic nicotine, including how it is made, how testing can distinguish it from tobacco-derived nicotine, and whether it poses its own unique health concerns. Following that review, the webinar will discuss perspectives on FDA’s authority to […]